How do you approach inpatient DVT prophylaxis in patients already on low dose rivaroxaban 2.5 mg BID for PAD?

I suspect that the approach to this situation may vary by provider given the lack of definitive evidence. ASH 2018 guidelines provide recommendations for inpatient thromboprophylaxis in acutely or critically ill patients. Generally, prophylactic LMWH is recommended over DOACs, but guidelines acknowl...